{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:25:52Z","timestamp":1788999952542,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajpc.2025.100983","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:10:18Z","timestamp":1743498618000},"page":"100983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Coronary microvascular dysfunction and its role in heart failure with preserved ejection fraction for future prevention and treatment"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-8028","authenticated-orcid":false,"given":"Rachel M","family":"Bond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tre'Cherie","family":"Crumbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Purewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samed","family":"Obang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Inder S","family":"Sraow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.100983_bib0001","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail Rev"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100983_bib0002","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpc.2025.100983_bib0003","series-title":"Coronary artery disease","year":"2021"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100983_bib0004","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC working group on coronary pathophysiology and microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease","volume":"116","author":"Padro","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100983_bib0005","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2025.100983_bib0006","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.15420\/cfr.2022.12","article-title":"Microvascular dysfunction in heart failure with preserved ejection fraction: pathophysiology, assessment, prevalence and prognosis","volume":"8","author":"Bilak","year":"2022","journal-title":"Card Fail Rev"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100983_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100294","article-title":"Sex differences in heart failure following acute coronary syndromes","volume":"2","author":"Cenko","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.ajpc.2025.100983_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2022.11.009","article-title":"Ischemia and no obstructive coronary arteries (INOCA): a narrative review","volume":"363","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.100983_bib0009","article-title":"Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease","volume":"8","author":"Leong","year":"2021","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"issue":"21","key":"10.1016\/j.ajpc.2025.100983_bib0010","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC State-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100983_bib0011","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"86","author":"Crea","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.ajpc.2025.100983_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115011","article-title":"Coronary microvascular dysfunction and cardiovascular disease: pathogenesis, associations and treatment strategies","volume":"164","author":"Yang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajpc.2025.100983_bib0013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phrs.2017.07.004","article-title":"Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome","volume":"123","author":"Labazi","year":"2017","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100983_bib0014","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.HYP.33.4.998","article-title":"Structural skin capillary rarefaction in essential hypertension","volume":"33","author":"Antonios","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2025.100983_bib0015","article-title":"Lp(a) and risk of cardiovascular disease - a review of existing evidence and emerging concepts","author":"Jasti","year":"2023","journal-title":"J Natl Med Assoc"},{"issue":"8","key":"10.1016\/j.ajpc.2025.100983_bib0016","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ajpc.2025.100983_bib0017","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2017.09.016","article-title":"Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries","volume":"70","author":"Aziz","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"47","key":"10.1016\/j.ajpc.2025.100983_bib0018","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100983_bib0019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/ar1814","article-title":"Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis","volume":"7","author":"Giles","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100983_bib0020","first-page":"404","article-title":"Acute on chronic severe aortic insufficiency due to rheumatoid arthritis-associated valvulitis","volume":"11","author":"Ivy","year":"2021","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.ajpc.2025.100983_bib0021","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acr.21861","article-title":"Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review","volume":"65","author":"Aslam","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.ajpc.2025.100983_bib0022","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/hc3201.094226","article-title":"Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?","volume":"104","author":"Zile","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100983_bib0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4330\/wjc.v12.i1.7","article-title":"Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction","volume":"12","author":"Henning","year":"2020","journal-title":"World J Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100983_bib0024","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/biom12020278","article-title":"The role of systemic microvascular dysfunction in heart failure with preserved ejection fraction","volume":"12","author":"Weerts","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100983_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.003779","article-title":"Diastolic backward-traveling decompression (Suction) wave correlates with simultaneously acquired indices of Diastolic function and is reduced in left ventricular stunning","volume":"9","author":"Ladwiniec","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100983_bib0026","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2013.09.039","article-title":"Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease)","volume":"63","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100983_bib0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2022.08.814","article-title":"Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week","volume":"81","author":"Boden","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.100983_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004457","article-title":"Racial differences in characteristics and outcomes of patients with heart failure and preserved ejection fraction in the treatment of preserved cardiac function heart failure trial","volume":"11","author":"Lewis","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100983_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100983_bib0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCIMAGING.109.854893","article-title":"Noninvasive assessment of myocardial perfusion","volume":"2","author":"Salerno","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100983_bib0031","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2012.03.014","article-title":"Invasive coronary vasoreactivity testing to diagnose microvascular dysfunction in women","volume":"5","author":"Bailey","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.ajpc.2025.100983_bib0032","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the national heart, lung and blood institute wise (women's ischemia syndrome evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100983_bib0033","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow outcomes reviewing committee. coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ajpc.2025.100983_bib0034","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.105.609990","article-title":"The economic burden of angina in women with suspected ischemic heart disease: results from the national institutes of health\u2013national heart, lung, and blood institute\u2013sponsored women's ischemia syndrome evaluation","volume":"114","author":"Shaw","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajpc.2025.100983_bib0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.CIR.0000115525.92645.16","article-title":"Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation (WISE)","volume":"109","author":"von Mering","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2025.100983_bib0036","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCHEARTFAILURE.115.002143","article-title":"Association between use of statins and mortality in patients with heart failure and ejection fraction of \u226550","volume":"8","author":"Alehagen","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100983_bib0037","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American college of cardiology solution set oversight committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ajpc.2025.100983_bib0038","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ajpc.2025.100983_bib0039","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.100983_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2021.03.011","article-title":"Rationale and design of the Women's Ischemia trial to reduce events in nonobstructive CAD (WARRIOR) trial","volume":"237","author":"Handberg","year":"2021","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2025.100983_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure","volume":"82","author":"Mentz","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"10.1016\/j.ajpc.2025.100983_bib0042","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: pROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.100983_bib0043","doi-asserted-by":"crossref","unstructured":"Zheng S.L., Chan F.T., Nabeebaccus A.A., Shah A.M., McDonagh T., Okonko D.O., Ayis S. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart. 2018 Mar;104(5):407\u201315. doi: 10.1136\/heartjnl-2017-311652. Epub 2017 Aug 5. PMID: 28780577; PMCID: PMC5861385.","DOI":"10.1136\/heartjnl-2017-311652"},{"key":"10.1016\/j.ajpc.2025.100983_bib0044","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-024-10439-1","article-title":"Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities","author":"Vacca","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ajpc.2025.100983_bib0045","doi-asserted-by":"crossref","unstructured":"Rehan R., Yong A., Ng M., Weaver J., Puranik R. Coronary microvascular dysfunction: a review of recent progress and clinical implications. Front Cardiovasc Med. 2023 Jan 26;10:1111721. doi: 10.3389\/fcvm.2023.1111721. PMID: 36776251; PMCID: PMC9908997.","DOI":"10.3389\/fcvm.2023.1111721"},{"issue":"18","key":"10.1016\/j.ajpc.2025.100983_bib0046","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIR.0000000000001182","article-title":"Food is medicine: a presidential advisory from the American Heart Association","volume":"148","author":"Volpp","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ajpc.2025.100983_bib0047","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2013.04.033","article-title":"Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial","volume":"62","author":"Kitzman","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ajpc.2025.100983_bib0048","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.15537\/smj.2023.44.12.20230427","article-title":"Enhanced external counterpulsation increases coronary flow reserve in coronary microvascular disease","volume":"44","author":"Wang","year":"2023","journal-title":"Saudi Med J"},{"issue":"11","key":"10.1016\/j.ajpc.2025.100983_bib0049","doi-asserted-by":"crossref","first-page":"ytac440","DOI":"10.1093\/ehjcr\/ytac440","article-title":"Implantation of the coronary sinus reducer for refractory angina due to coronary microvascular dysfunction in the context of apical hypertrophic cardiomyopathy-a case report","volume":"6","author":"Cheng","year":"2022","journal-title":"Eur Heart J Case Rep"},{"issue":"2","key":"10.1016\/j.ajpc.2025.100983_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.010802","article-title":"Autologous CD34+ stem cell therapy increases coronary flow reserve and reduces angina in patients with coronary microvascular dysfunction","volume":"15","author":"Henry","year":"2022","journal-title":"Circ Cardiovasc Interv"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T15:35:18Z","timestamp":1751988918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S2666667725000558"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.100983","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary microvascular dysfunction and its role in heart failure with preserved ejection fraction for future prevention and treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.100983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100983"}}